Company / Return on Equity (ROE)
PURE BIOSCIENCE, INC. Return on Equity (ROE) History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-1456.3%
FY2023
5-year range
-1456.3% / -69.6%
FY2019-FY2023
Trend
-1530.6%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PURE BIOSCIENCE, INC. reports negative total equity of -1456.3% in FY2023. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-1456.3% in FY2023 with a 5-year CAGR of -875.3%.
Declined from -69.6% to -1456.3% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -1456.3pp
- 5-Year Change
- -875.3pp
- 10-Year Change
- -
Key checks
Key Insights
- PURE BIOSCIENCE, INC.'s return on equity (roe) has declined for 3 consecutive years.
- In FY2023, return on equity (roe) decreased 1530.6% year-over-year.
- Peak return on equity (roe) was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -116.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | -1456.3% | -1530.6% |
| FY2022 | -89.3% | -28.4% |
| FY2021 | -69.6% | -87075.0% |
| FY2020 | 0.1% | +100.0% |
| FY2019 | -550.8% | +5.2% |
| FY2018 | -581.0% | -19.7% |
| FY2017 | -485.5% | -69.7% |
| FY2016 | -286.1% | +10.6% |
As of FY2023 · SEC Form 10-K · Last checked Jun 29, 2026